ATE281835T1 - Fettemulsion, die ein xanthinderivat enthält - Google Patents
Fettemulsion, die ein xanthinderivat enthältInfo
- Publication number
- ATE281835T1 ATE281835T1 AT97934737T AT97934737T ATE281835T1 AT E281835 T1 ATE281835 T1 AT E281835T1 AT 97934737 T AT97934737 T AT 97934737T AT 97934737 T AT97934737 T AT 97934737T AT E281835 T1 ATE281835 T1 AT E281835T1
- Authority
- AT
- Austria
- Prior art keywords
- fat emulsion
- xanthine derivative
- emulsion containing
- hydroxyl
- substituted
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Dispersion Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Colloid Chemistry (AREA)
- Edible Oils And Fats (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22439996 | 1996-08-07 | ||
PCT/JP1997/002773 WO1998005334A1 (en) | 1996-08-07 | 1997-08-07 | Fat emulsion containing xanthine derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE281835T1 true ATE281835T1 (de) | 2004-11-15 |
Family
ID=16813150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97934737T ATE281835T1 (de) | 1996-08-07 | 1997-08-07 | Fettemulsion, die ein xanthinderivat enthält |
Country Status (15)
Country | Link |
---|---|
US (1) | US6210687B1 (de) |
EP (1) | EP0958821B1 (de) |
JP (2) | JP4179631B2 (de) |
KR (1) | KR20000029672A (de) |
CN (1) | CN1227490A (de) |
AT (1) | ATE281835T1 (de) |
AU (1) | AU3784597A (de) |
CA (1) | CA2262578A1 (de) |
DE (1) | DE69731556T2 (de) |
DK (1) | DK0958821T3 (de) |
ES (1) | ES2232877T3 (de) |
NZ (1) | NZ334299A (de) |
PT (1) | PT958821E (de) |
SI (1) | SI0958821T1 (de) |
WO (1) | WO1998005334A1 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020123538A1 (en) * | 2000-12-29 | 2002-09-05 | Peiguang Zhou | Hot-melt adhesive based on blend of amorphous and crystalline polymers for multilayer bonding |
US20040229901A1 (en) * | 2003-02-24 | 2004-11-18 | Lauren Otsuki | Method of treatment of disease using an adenosine A1 receptor antagonist |
WO2004096228A1 (en) * | 2003-04-25 | 2004-11-11 | Novacardia, Inc. | Method of improved diuresis in individuals with impaired renal function |
US20060293312A1 (en) * | 2003-04-25 | 2006-12-28 | Howard Dittrich | Method of improved diuresis in individuals with impaired renal function |
EP1932529A1 (de) | 2003-04-25 | 2008-06-18 | Novacardia, Inc. | Verfahren zur verbesserten Harnausscheidung bei Personen mit beeinträchtiger Nierenfunktion |
WO2005105083A1 (en) * | 2004-04-16 | 2005-11-10 | Novacardia, Inc. | Combination therapy comprising an adenosine a1 receptor antagonist and an aldosterone inhibitor |
CA2608111A1 (en) * | 2005-04-22 | 2006-11-02 | Novacardia, Inc. | Production of emulsions for intravenous injection of water-insoluble pharmaceutical compositions |
US7893070B2 (en) | 2005-08-15 | 2011-02-22 | Provimi Holding B.V. | Method of treating parturient placental mammals in order to reduce maternal and/or uterine exhaustion |
EP1915156B1 (de) * | 2005-08-15 | 2012-07-11 | Provimi Holding B.V. | Verwendung von psychomotorische stimulantien in einem verfahren zur behandlung gebärender plazentaler säuger zur verminderung von maternaler und/oder uteriner erschöpfung |
EP1961422A1 (de) * | 2005-12-14 | 2008-08-27 | Kyowa Hakko Kogyo Co., Ltd. | Einfach absorbiertes orales präparat mit einem xanthin-derivat |
JP2009532479A (ja) * | 2006-04-06 | 2009-09-10 | ノヴァカーディア,インク. | アデノシンa1受容体アンタゴニストと抗痙攣薬の同時投与 |
WO2007149366A1 (en) * | 2006-06-16 | 2007-12-27 | Novacardia, Inc. | Prolonged improvement of renal function comprising infrequent administration of an aa1ra |
US20080242684A1 (en) * | 2007-03-29 | 2008-10-02 | Howard Dittrich | Methods of administration of adenosine a1 receptor antagonists |
WO2008121893A1 (en) * | 2007-03-29 | 2008-10-09 | Novacardia, Inc. | Methods of treating heart failure and renal dysfunction in individuals with an adenosine a1 receptor antagonist |
HUE026295T2 (en) | 2010-10-12 | 2016-06-28 | The Medicines Co | Clevidipine emulsion formulations containing antimicrobial agents |
US8658676B2 (en) | 2010-10-12 | 2014-02-25 | The Medicines Company | Clevidipine emulsion formulations containing antimicrobial agents |
JP7331417B2 (ja) | 2019-03-29 | 2023-08-23 | セイコーエプソン株式会社 | メディア支持構造及び記録装置 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4146621A (en) * | 1973-01-16 | 1979-03-27 | The Regents Of The University Of Michigan | Process of treating proliferative skin diseases |
JPH0647533B2 (ja) * | 1984-08-10 | 1994-06-22 | 裕 水島 | 4−ビフエニリル酢酸系化合物含有脂肪乳剤 |
ES2039219T3 (es) | 1986-08-11 | 1993-09-16 | American Cyanamid Company | Composiciones para administracion parenteral y su uso. |
JPH0559056A (ja) | 1991-02-25 | 1993-03-09 | Kyowa Hakko Kogyo Co Ltd | キサンチン誘導体 |
CA2093403C (en) * | 1992-04-08 | 1999-08-10 | Fumio Suzuki | Therapeutic agent for parkinson's disease |
WO1994016702A1 (en) * | 1993-01-26 | 1994-08-04 | Kyowa Hakko Kogyo Co., Ltd. | Remedy for irregular bowel movement |
JP3729874B2 (ja) * | 1993-04-07 | 2005-12-21 | 協和醗酵工業株式会社 | キサンチン誘導体 |
US5395836A (en) * | 1993-04-07 | 1995-03-07 | Kyowa Hakko Kogyo Co., Ltd. | 8-tricycloalkyl xanthine derivatives |
JPH07285863A (ja) * | 1994-02-25 | 1995-10-31 | Takeda Chem Ind Ltd | 注射剤組成物およびその製造方法 |
JPH0881360A (ja) * | 1994-07-13 | 1996-03-26 | Wakamoto Pharmaceut Co Ltd | 安定な脂肪乳剤 |
JP4008965B2 (ja) * | 1994-07-29 | 2007-11-14 | 昭和産業株式会社 | レシチン含有脂肪乳剤の調製法 |
JPH08104620A (ja) * | 1994-10-05 | 1996-04-23 | Green Cross Corp:The | 薬物含有脂肪乳剤 |
-
1997
- 1997-08-07 WO PCT/JP1997/002773 patent/WO1998005334A1/ja active IP Right Grant
- 1997-08-07 DE DE69731556T patent/DE69731556T2/de not_active Expired - Lifetime
- 1997-08-07 ES ES97934737T patent/ES2232877T3/es not_active Expired - Lifetime
- 1997-08-07 CN CN97197092A patent/CN1227490A/zh not_active Withdrawn
- 1997-08-07 US US09/230,984 patent/US6210687B1/en not_active Expired - Fee Related
- 1997-08-07 DK DK97934737T patent/DK0958821T3/da active
- 1997-08-07 AU AU37845/97A patent/AU3784597A/en not_active Abandoned
- 1997-08-07 NZ NZ334299A patent/NZ334299A/xx unknown
- 1997-08-07 JP JP50782298A patent/JP4179631B2/ja not_active Expired - Fee Related
- 1997-08-07 KR KR1019997000750A patent/KR20000029672A/ko not_active Application Discontinuation
- 1997-08-07 AT AT97934737T patent/ATE281835T1/de not_active IP Right Cessation
- 1997-08-07 EP EP97934737A patent/EP0958821B1/de not_active Expired - Lifetime
- 1997-08-07 CA CA002262578A patent/CA2262578A1/en not_active Abandoned
- 1997-08-07 PT PT97934737T patent/PT958821E/pt unknown
- 1997-08-07 SI SI9730675T patent/SI0958821T1/xx unknown
-
2008
- 2008-05-27 JP JP2008137775A patent/JP2008231117A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ES2232877T3 (es) | 2005-06-01 |
JP2008231117A (ja) | 2008-10-02 |
SI0958821T1 (en) | 2005-02-28 |
AU3784597A (en) | 1998-02-25 |
DE69731556T2 (de) | 2005-10-27 |
EP0958821A1 (de) | 1999-11-24 |
KR20000029672A (ko) | 2000-05-25 |
JP4179631B2 (ja) | 2008-11-12 |
EP0958821A4 (de) | 2003-05-02 |
WO1998005334A1 (en) | 1998-02-12 |
CA2262578A1 (en) | 1998-02-12 |
DE69731556D1 (de) | 2004-12-16 |
EP0958821B1 (de) | 2004-11-10 |
CN1227490A (zh) | 1999-09-01 |
DK0958821T3 (da) | 2005-01-03 |
PT958821E (pt) | 2005-02-28 |
US6210687B1 (en) | 2001-04-03 |
NZ334299A (en) | 1999-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE281835T1 (de) | Fettemulsion, die ein xanthinderivat enthält | |
DE69628276D1 (de) | Zubereitung von xanthinderivaten als feste dispersion | |
PT705833E (pt) | Derivado de dc-89 | |
FI970803A (fi) | Ei-spesifisen hybridisaation vähentäminen uusilla emäsparien muodostuskaavoilla | |
HU9501151D0 (en) | Substituted pyridylpyrazoles | |
ATE176470T1 (de) | Xanthinderivate | |
AU9281198A (en) | Benzofuran derivatives | |
KR850006187A (ko) | 신규 히달토인(Hydantoin) 유도체의 제조방법 | |
EP1454903A4 (de) | Thiadiazolinderivat | |
ATE146481T1 (de) | Epoxysuccinamidsäurederivat | |
DE69906243T2 (de) | 2-Indanmethanolderivate und ihre Verwendung als Riechstoffe | |
TNSN98119A1 (fr) | Nouveaux derives de 4-hydroxy-2h-1-(thio)pyran-2-ones, leurs preparations et leurs utilisations comme rodonticides. | |
DE69631521D1 (de) | Propenonderivate | |
ES2109962T3 (es) | Derivados de la naftiridina condensados. | |
DK0661273T3 (da) | Indanderivater og fremgangsmåder til fremstilling af samme | |
KR890005110A (ko) | 신규의 3-아로일-6,7-디히드로-5h-피롤로[1,2-c]이미다졸-7-카르복시산유도체 | |
DE69231244T2 (de) | Pyrazolothiazolopyrimidin-derivate | |
FR2671096B1 (fr) | Production d'huile de tall. | |
EP0278008A4 (de) | Verbindungen vom taurintyp. | |
KR870007879A (ko) | 노르보르난계 술폰아미드 유도체의 제조방법 | |
TH15423A (th) | อนุพันธ์ไธอะโซโลพิริมิดีน |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0958821 Country of ref document: EP |
|
EEFA | Change of the company name | ||
REN | Ceased due to non-payment of the annual fee |